Skip to content
  • Who We Are
  • Our Products
    Products
    • Our Products
    • THALIDOMIDE (TALDO)
    • CISPLATIN (HYALCIS)
    • AMIKACIN (AMIKA PS)
    • TOBRAMYCIN (TOBRA PS)
    THALIDOMIDE
    • EMA Public Summary of opinion on orphan designation for Thalidomide
    • EMA summary report for Thalidomide
    • EMA Opinion of the Commitee for Orphan Medicinal Products on orphan medicinal product desigantion For Thalidomide
    CISPLATIN
    • EMA Public Summary of opinion on orphan designation for Cisplatin
    • EMA summary report for Cisplatin
    • EMA Opinion of the Commitee for Orphan Medicinal Products on orphan medicinal product desigantion For Cispaltin
    AMIKACIN
    • EMA Public Summary of opinion on orphan designation for Amikacin
    • Plumestars’s Scientific Pubblications
  • Our Video
  • News
    • News
    • Events
    • Awards
    • Press
    • Government Grants
    • About Us
  • Plumestars Activities
    • Plumestars & Cupido Project
    • Plumestars’s Scientific Pubblications
    • PlumeStars NEW SERVICES and ACTIVITIES
  • Ethics
  • Contact Us

Mese: Dicembre 2018

PlumeSTARS’s Christmas Greetings

Dear All,

on behalf of the PlumeSTARS’s Team wish you a wonderful holiday season and a happy new year!

PlumeStars, DDL 2018

PlumeSTARS attended at the DDL 2018

PlumeSTARS actively participated at the DDL 2018 , Drug delivery to the Lungs conference held on 12, 13 and 14 December at Edinburgh.

The Drug Delivery to the Lungs conference (DDL) is Europe’s premier conference and industry exhibition which is dedicated to pulmonary and nasal drug delivery.

Read more “PlumeSTARS attended at the DDL 2018”

Privacy Policy
Copyright © PlumeStars s.r.l.
Viale Parco Area delle Scienze 27/A
43124 Parma (PR), Italy
P.IVA C.F. 02698350341
Archivio
Meta
  • Accedi
  • Feed dei contenuti
  • Feed dei commenti
  • WordPress.org